High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump.

Abstract

AIM:

The aim of this study was to determine the prevalence of likely eating disorders and insulin misuse in a prospective cohort of adults with type 1 diabetes mellitus (T1DM) treated with insulin pump therapy.

METHODS:

This prospective study was held at the participants' home. The participants completed the SCOFF questionnaire as well as a question related to insulin misuse. Information about lifestyle, medical history, insulin pump and Continuous Glucose Monitoring (CGM) data were collected.

RESULTS:

The analysis covered 198 participants with a median age of 51 [95% CI 38; 62] years. The prevalence of likely eating disorders was 21.7% (95% CI 16.3; 28.2) in the study population and 20.6% (95% CI 14.3; 28.6) and 24.2% (95% CI 14.6; 37.0) in males and females respectively. The prevalence of insulin misuse was 39.0% (95% CI 30.8; 47.7). There was no significant difference in prevalence between males and females for likely eating disorders and insulin misuse. The analysis of CGM data revealed no factors related to glycaemic control associated with likely eating disorders.

CONCLUSION:

The results of this study indicate that the prevalence of likely eating disorders is high even in a middle-aged population with a T1DM and satisfactory glucose control.

• Authors: Laura Albaladejo, Pauline Périnet-Marquet, Claire Buis, Sandrine Lablanche, Sylvain Iceta, Nathalie Arnol, Sophie Logerot, Jean-Christian Borel, Cécile Bétry
• Journal: Diabetes research and clinical practice (Diabetes Res Clin Pract) Vol. 199 Pg. 110630 (May 2023) ISSN: 1872-8227 [Electronic] Ireland
• PMID: 36934794 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 Elsevier B.V. All rights reserved.

Chemical References

• Blood Glucose
• Insulin
• Insulin, Regular, Human
• Hypoglycemic Agents

Topics

• Adult
• Male
• Middle Aged
• Female
• Humans
• Diabetes Mellitus, Type 1 (drug therapy, epidemiology, complications)
• Prospective Studies
• Blood Glucose Self-Monitoring (methods)
• Prevalence
• Blood Glucose
• Insulin (therapeutic use)
• Insulin Infusion Systems
• Feeding and Eating Disorders (epidemiology, complications)
• Insulin, Regular, Human (therapeutic use)
• Hypoglycemic Agents (therapeutic use)